Avid Bioservices is a full-service, dedicated contract development and manufacturing organization (CDMO) focused on development and manufacturing of biopharmaceutical drug substances derived from mammalian cell culture. Avid’s biologics development and manufacturing services include process development and current good manufacturing practice (CGMP) clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submissions support. For early stage programs, the company provides various process development activities, including upstream and downstream development and optimization, analytical methods development, testing, and characterization. Avid has 27 years of experience producing a comprehensive range of proteins, including monoclonal antibodies (MAbs) and recombinant proteins as well as bispecific monoclonal antibodies, Fc-fusion proteins, and biosimilars. The scope of our services ranges from stand-alone process development projects to full development and manufacturing programs through commercialization.

Fill out the form below to read the capabilities review now.